Schedule 13G ownership disclosure

Mineralys Therapeutics Inc

Security class unavailable · CUSIP: 603170101

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-022655
Form type
SC 13G
Filer
ADAMS STREET PARTNERS LLC
CIK
CIK 1193586
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub